Gemayel Georges is a director of Disc Medicine Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
SUPERNUS PHARMACEUTICALS, INC.
27 Feb 24
4
SUPERNUS PHARMACEUTICALS, INC.
26 Feb 24
4
Disc Medicine, Inc.
9 Jun 23
4
SUPERNUS PHARMACEUTICALS, INC.
27 Feb 23
4
SUPERNUS PHARMACEUTICALS, INC.
24 Feb 23
4
Disc Medicine, Inc.
3 Jan 23
4
SUPERNUS PHARMACEUTICALS, INC.
24 Feb 22
4
SUPERNUS PHARMACEUTICALS, INC.
23 Feb 22
4
Gemini Therapeutics, Inc. /DE
5 Jan 22
4
Gemini Therapeutics, Inc. /DE
16 Nov 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Feb 24 | SUPN Supernus Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 3,886 | 0.00 | 17,201 |
23 Feb 24 | SUPN Supernus Pharmaceuticals | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,886 | 0.00 | 0 |
22 Feb 24 | SUPN Supernus Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 5,369 | 0.00 | 5,369 |
22 Feb 24 | SUPN Supernus Pharmaceuticals | Director Stock Option Common Stock | Grant | Acquire A | No | No | 27.94 | 8,252 | 230.56 k | 8,252 |
9 Jun 23 | IRON Disc Medicine | Stock Option Common Stock | Grant | Acquire A | No | No | 45.69 | 7,136 | 326.04 k | 7,136 |
23 Feb 23 | SUPN Supernus Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 3,886 | 0.00 | 3,886 |
23 Feb 23 | SUPN Supernus Pharmaceuticals | Director Stock Option Common Stock | Grant | Acquire A | No | No | 38.6 | 6,293 | 242.91 k | 6,293 |
22 Feb 23 | SUPN Supernus Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 3,882 | 0.00 | 13,315 |
22 Feb 23 | SUPN Supernus Pharmaceuticals | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,882 | 0.00 | 0 |